|
Novoray Corporation (688300.SS) DCF -Bewertung
CN | Basic Materials | Chemicals - Specialty | SHH
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Novoray Corporation (688300.SS) Bundle
Unabhängig davon, ob Sie Investor oder Analyst sind, ist dieser (688300S) DCF-Taschenrechner Ihre Anlaufstelle für eine genaue Bewertung. Ausgestattet mit echten Daten der Novoray Corporation können Sie Prognosen anpassen und die Auswirkungen in Echtzeit beobachten.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 315.3 | 404.2 | 624.7 | 662.0 | 711.7 | 882.9 | 1,095.3 | 1,358.7 | 1,685.6 | 2,091.1 |
| Revenue Growth, % | 0 | 28.2 | 54.55 | 5.96 | 7.51 | 24.06 | 24.06 | 24.06 | 24.06 | 24.06 |
| EBITDA | 100.8 | 145.0 | 220.6 | 231.8 | 249.5 | 305.9 | 379.4 | 470.7 | 583.9 | 724.4 |
| EBITDA, % | 31.96 | 35.87 | 35.31 | 35.01 | 35.06 | 34.64 | 34.64 | 34.64 | 34.64 | 34.64 |
| Depreciation | 12.2 | 16.3 | 22.9 | 36.4 | 49.7 | 42.5 | 52.7 | 65.3 | 81.1 | 100.6 |
| Depreciation, % | 3.88 | 4.02 | 3.67 | 5.49 | 6.98 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 |
| EBIT | 88.5 | 128.7 | 197.7 | 195.4 | 199.9 | 263.4 | 326.8 | 405.4 | 502.9 | 623.9 |
| EBIT, % | 28.08 | 31.85 | 31.64 | 29.52 | 28.08 | 29.83 | 29.83 | 29.83 | 29.83 | 29.83 |
| Total Cash | 447.6 | 156.4 | 350.6 | 411.4 | 565.1 | 593.9 | 736.8 | 914.1 | 1,134.0 | 1,406.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 171.2 | 233.8 | 310.3 | 304.4 | 298.1 | 440.9 | 546.9 | 678.5 | 841.7 | 1,044.2 |
| Account Receivables, % | 54.3 | 57.85 | 49.66 | 45.98 | 41.88 | 49.94 | 49.94 | 49.94 | 49.94 | 49.94 |
| Inventories | 45.6 | 54.4 | 76.2 | 77.1 | 85.9 | 112.7 | 139.8 | 173.5 | 215.2 | 267.0 |
| Inventories, % | 14.45 | 13.46 | 12.21 | 11.64 | 12.07 | 12.77 | 12.77 | 12.77 | 12.77 | 12.77 |
| Accounts Payable | 63.8 | 70.8 | 100.8 | 142.7 | 122.0 | 163.5 | 202.9 | 251.7 | 312.2 | 387.3 |
| Accounts Payable, % | 20.25 | 17.53 | 16.14 | 21.56 | 17.14 | 18.52 | 18.52 | 18.52 | 18.52 | 18.52 |
| Capital Expenditure | -60.3 | -124.1 | -208.0 | -154.8 | -53.0 | -201.3 | -249.7 | -309.7 | -384.2 | -476.7 |
| Capital Expenditure, % | -19.14 | -30.71 | -33.29 | -23.39 | -7.45 | -22.8 | -22.8 | -22.8 | -22.8 | -22.8 |
| Tax Rate, % | 11.84 | 11.84 | 11.84 | 11.84 | 11.84 | 11.84 | 11.84 | 11.84 | 11.84 | 11.84 |
| EBITAT | 76.2 | 111.2 | 173.1 | 190.5 | 176.2 | 234.8 | 291.2 | 361.3 | 448.2 | 556.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -124.9 | -61.1 | -80.2 | 118.9 | 149.6 | -52.2 | .4 | .5 | .6 | .7 |
| WACC, % | 8.73 | 8.73 | 8.73 | 8.74 | 8.73 | 8.73 | 8.73 | 8.73 | 8.73 | 8.73 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -46.4 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 1 | |||||||||
| Terminal Value | 16 | |||||||||
| Present Terminal Value | 11 | |||||||||
| Enterprise Value | -36 | |||||||||
| Net Debt | -74 | |||||||||
| Equity Value | 38 | |||||||||
| Diluted Shares Outstanding, MM | 185 | |||||||||
| Equity Value Per Share | 0.20 |
What You Will Receive
- Authentic Novoray Financials: Provides both historical and projected data for precise valuation.
- Customizable Parameters: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Real-Time Calculations: Intrinsic value and NPV are computed automatically.
- Comprehensive Scenario Analysis: Explore various scenarios to assess Novoray's future prospects.
- User-Friendly Design: Crafted for experts while remaining easy to use for novices.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Novoray Corporation (688300SS).
- WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable input parameters.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates as needed.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specifically for Novoray Corporation (688300SS).
- Visual Dashboard and Charts: Graphical representations present essential valuation metrics for simplified analysis.
How It Works
- Step 1: Download the prebuilt Excel template that contains Novoray Corporation (688300SS) data.
- Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Adjust the forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see the recalculated results, including Novoray Corporation's intrinsic value.
- Step 5: Utilize the outputs to make informed investment decisions or generate reports.
Why Choose Novoray Corporation (688300SS) Calculator?
- User-Friendly Interface: Tailored for both novices and seasoned users.
- Customizable Inputs: Adjust assumptions effortlessly to suit your analysis needs.
- Real-Time Valuation: Observe immediate updates to Novoray Corporation's valuation as you modify inputs.
- Preloaded Data: Comes equipped with Novoray's actual financial information for swift evaluations.
- Relied Upon by Experts: A preferred tool among investors and analysts for informed decision-making.
Who Can Benefit from Novoray Corporation (688300SS)?
- Individual Investors: Gain insights to make informed choices when trading Novoray Corporation (688300SS) stock.
- Financial Analysts: Enhance valuation assessments with readily available financial models for Novoray Corporation (688300SS).
- Consultants: Provide accurate and timely valuation insights regarding Novoray Corporation (688300SS) to clients.
- Business Owners: Learn how large firms like Novoray Corporation (688300SS) are valued to inform your strategic decisions.
- Finance Students: Explore valuation methodologies through practical examples involving Novoray Corporation (688300SS).
Contents of the Template
- Comprehensive DCF Model: An editable template featuring intricate valuation calculations.
- Real-World Data: Novoray Corporation’s historical and projected financials preloaded for in-depth analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Detailed annual and quarterly breaks for enhanced insights.
- Key Ratios: Integrated analysis covering profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Includes charts and tables to present clear and actionable results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.